Baird analyst Michael Ha initiated coverage of Tenet Healthcare with an Outperform rating and $153 price target. The firm started coverage on three Hospital companies with two having Outperform ratings and one with a Neutral rating. Baird believes Hospitals remain well positioned in 2024 to outperform expectations, but long term it remains cautious on the potential secular headwind that could be driven by Value Based Care, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet call volume above normal and directionally bullish
- Tenet Healthcare price target raised to $147 from $113 at Barclays
- Tenet Healthcare price target raised to $130 from $120 at Truist
- Tenet Healthcare price target raised to $136 from $109 at RBC Capital
- Tenet Healthcare price target raised to $122 from $95 at Stephens